who discovered glp-1 agonists Discovery of GLP-1–Based Drugs for the Treatment of Obesity Who should win a Nobel
Description
In addition, post-prandial blood glucose reduction by dulaglutide was superior to insulin glargine
Session 1 After informed consent was obtained, participants completed a Timeline Follow Back (TLFB) to measure drinking in the past 30 days, Patient Health Questionnaire (PHQ-9), and a medical interview which asked about current and past medication history and other medical history to ensure safe participation in the study, as reviewed by a study physician
July 6, 2022
Efpeglenatide, an exendin 4-based molecule, also showed a significant reduction in major adverse cardiovascular events (7.0% vs
Oral drugs are designated as orange dots, and blue designates the injectable treatments
